3,131 press releases indexed under healthcare.
Application based on long-term safety and efficacy data from three ongoing studies, including adult height and additional clinical outcomes beyond linear growth, including body proportionality and arm span evaluated over long-term follow-up FDA PDUFA target action date of Feb. 28, 2027...
(PR-inside.com) Health Insurance Now offers private options to middle-income families squeezed by the 2026 subsidy cliff. BOCA RATON, FL / ACCESS Newswire / July 13, 2026 / Health Insurance Now is reaching middle-income households hit hardest by the 2026 changes to health insurance subsidies, a group earning just above the eligibility threshold that has left the Marketplace in disproportionate numbers. For these families,health insurance private planshave become the practical path to coverage once premium tax credits fall away. Reporting on early 2026 enrollment found that people with incomes between 400 percent and 500 percent of the federal poverty level accounted for about 27 ..
COPENHAGEN, Denmark, July 13, 2026 – Bavarian Nordic A/S (OMX: BAVA) today announced that its partner, Eurofarma, has submitted a marketing authorization application to the Brazilian Health Regulatory Agency (Anvisa) for Bavarian Nordic’s chikungunya vaccine, CHIKV VLP, for the prevention of disease caused by chikungunya virus in individuals 12 years of age and older.
PARIS, July 13, 2026 (GLOBE NEWSWIRE) -- Cadrenal Therapeutics, Inc. (Nasdaq: CVKD), a late-stage biopharmaceutical company advancing novel therapies for rare immunothrombotic conditions, announced today that late-breaking clinical data from the Phase 2 study of the first-in-class 12-lipoxygenase (12-LOX) inhibitor CAD-1005 were featured in a highly anticipated late-breaking oral presentation at the International Society on Thrombosis and Haemostasis (ISTH) 2026 Congress in Paris.
Health Insurance Now offers private options to middle-income families squeezed by the 2026 subsidy cliff.
Magna Legal Services, a nationwide leader in court reporting, medical record retrieval, litigation consulting, investigations and service of process, has combined with Naegeli Deposition & Trial. The transaction became effective on Thursday, July 9 and was led by John Brownschidle, Head...
Omada Health (Nasdaq: OMDA) announced that members of senior management will participate in Canaccord Genuity’s 46th annual Growth Conference.
Oncolytics announced more than 20 patients pre-identified for REO 033 colorectal cancer trial and scheduled Type D meeting with the FDA.
PDS Optical is pioneering a new front in Veteran healthcare with the launch of the Pulse on Digital Strain Survey. This first-of-its-kind initiative is specifically designed to uncover how modern screen time affects the vision health of the Veteran community, a population previously...
New data show 96% opioid abstinence rates among long-term patients as statewide overdose deaths begin to decline. RENTON, Wash., July 13, 2026 /PRNewswire-PRWeb/ -- Ideal Option, a national leader in outpatient medication-assisted treatment (MAT) for addiction to opioids, stimulants and...
Physician-scientist and immunology leader joins Cue as the company advances key clinical programs in allergic and autoimmune diseases Physician-scientist and immunology leader joins Cue as the company advances key clinical programs in allergic and autoimmune diseases